πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 763 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7150869

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7141234

Imaging of drug accumulation as a guide to antitumor therapy

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7125541

Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy

THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS Β· Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7109303

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7098191

Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7094413

Combined therapy for treatment of HIV infection

The Regents of the University of California Β· Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7067653

Porphyrin Based neuton capture agents for cancer therapy

The Regents of the University of California Β· Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7037680

Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7037904

Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing

Third Military Medical University, Chinese People's Liberation Army, P.R. of China Β· Granted Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7008633

Local regional chemotherapy and radiotherapy using in situ hydrogel

The Board of Regents of the University of Texas System Β· Granted Tue Mar 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7005424

Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells

The Board of Regents of the University of Texas System Β· Granted Tue Feb 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7001602

Use of botulinum toxin therapy for urinary incontinence and related disorders

The Regents of the University of Colorado Β· Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6984379

Gene therapy by administration of genetically engineered CD34+ cells obtained from cord bl

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6982168

Immortal human prostate epithelial cell lines and clones and their applications in the res

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6936599

Estriol therapy for multiple sclerosis and other autoimmune diseases

The Regents of the University of California Β· Granted Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6906050

Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy,

Miravant Pharmaceuticals, Inc. Β· Granted Tue Jun 14 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6887862

Method for improving treatment selectivity and efficacy using intravascular photodynamic t

Miravant Systems, Inc. Β· Granted Tue May 03 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6867190

Methods of therapy with thrombin derived peptides

The Board of Regents of the University of Texas System Β· Granted Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6863885

Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6861407

Methods of therapy with thrombin derived peptides

The Board of Regents of the University of Texas System Β· Granted Tue Mar 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6827926

Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy

Miravant Pharmaceuticals, Inc. Β· Granted Tue Dec 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6821522

Tumor Therapy

The Regents of the University of California Β· Granted Tue Nov 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6815431

Methods for therapy of neurodegenerative disease of the brain

The Regents of the University of California Β· Granted Tue Nov 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6806080

Hybrid vectors for gene therapy

The Regents of the University of California Β· Granted Tue Oct 19 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired